New Fortress checkweigher for SME and dairy Designed for the SME and dairy sector to offset inflation and farmgate price hikes – notably rising grain feed prices and higher production costs – Fortress Technology is launching its new Raptor Checkweigher at Foodex 2021.
Created for artisan food businesses to improve profit margins by driving down expensive overfilling, the new Raptor Checkweigher is the company’s most high spec economic checkweigher for washdown environments. By reducing product giveaway on premium product lines, the company said the payment is fast. In some cases, predicted ROI can be several weeks or less.
At the start of 2021, global food prices hit a six-year high. Already hit by income losses during the pandemic, now the cost of food staples, including essential ingredients such as grains, sugar, soybeans, corn, cocoa and spices, is impacting pricing strategies and profits for many SMEs.
Elopak aims for IPO in June Norwegian packaging company Elopak is preparing to apply for listing on the Oslo Stock Exchange, with the goal of being listed this June.
The company said the initial public offering (IPO) will ensure access to capital markets to support the company s innovation and growth ambitions.
Elopak develops and produces carton packaging and filling machines, including in the beverages and liquid food segment. It sells 14bn cartons annually, in more than 70 markets worldwide. Elopak said an IPO will ensure sufficient access to capital and support its expansion into new markets, further investments in new products and technology, and potential acquisitions. Stricter regulations for plastic packaging, increased consumer demand for sustainable products and growing efforts to transition to a low carbon circular economy are important market drivers shaping the company’s plans.
TurtleTree, a biotech company using mammalian cells to produce cell-based milk, is now eyeing how its tech can be transferred to the functional foods space.
DSM’s new venture Hologram Sciences plans to run a blood sugar management trial in Singapore to study how personalised approaches can help address pre-diabetes concerns, we can exclusively reveal.